ESPR Stock-Based Compensation
Esperion Therapeutics Inc · Stock-Based Compensation
ESPR Stock-Based Compensation
Latest reported$9.91Mperiod ending
ESPR TTM Stock-Based Comp ($0.00 → $9.91M)
TTM stock-based compensation
High-resolution chart · PNG
ESPR stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 9,907,000 | |
| 9,870,000 | |
| 10,288,000 | |
| 10,961,000 | |
| 11,223,000 | |
| 11,993,000 | |
| 12,108,000 | |
| 12,061,000 | |
| 12,290,000 | |
| 11,958,000 | |
| 12,753,000 | |
| 13,315,000 | |
| 13,682,000 | |
| 15,215,000 | |
| 15,974,000 | |
| 17,934,000 | |
| 22,991,000 | |
| 24,306,000 | |
| 26,505,000 | |
| 28,272,000 | |
| 27,083,000 | |
| 28,385,000 | |
| 28,070,000 | |
| 27,133,000 | |
| 26,301,000 | |
| 25,884,000 | |
| 26,355,000 | |
| 25,523,000 | |
| 24,683,000 | |
| 23,968,000 | |
| 21,673,000 | |
| 21,119,000 | |
| 20,376,000 | |
| 18,605,000 | |
| 17,642,000 | |
| 16,410,000 | |
| 15,551,000 | |
| 15,957,000 | |
| 16,771,000 | |
| 16,433,000 | |
| 15,210,000 | |
| 12,726,000 | |
| 9,394,000 | |
| 6,973,000 | |
| 5,010,000 | |
| 3,679,000 | |
| 3,179,744 | |
| 2,749,576 | |
| 1,913,016 | |
| 1,226,988 | |
| 692,527 | |
| 201,974 | |
| 118,691 | |
| 79,861 | |
| 60,578 | |
| 31,299 | |
| 16,142 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |